Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AEHR TEST SYSTEMSAEHR · Entity 2640 | Director | August 14, 2026 | August 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AEHR TEST SYSTEMS
Report date August 14, 2026 · Filed August 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 381,989 |
Reported balance
After 2026-08-14 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-08-14 · Sale · Disposed 5,973 · Balance 381,989 |
| Common StockSEC Table I · non-derivative | Direct | 47,156 |
Reported balance
Holding disclosure · report date 2026-08-14 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 47,156 F1: The amount reported includes shares subject to unvested restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: The amount reported includes shares subject to unvested restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 14, 2026 Filed Aug 14, 2026 21:46 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 5,973 | $140.00 | $836,220.00 |
DisclosureSEC source: 0001040470-26-000255 · primary_01.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 381,989 Read SEC document |
| August 12, 2026 Filed Aug 13, 2026 21:28 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 8,413 | $130.00 | $1,093,690.00 |
DisclosureSEC source: 0001040470-26-000249 · primary_01.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 387,962 Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 21:18 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 1,895 | $0.00 | $0.00 |
DisclosureSEC source: 0001040470-26-000173 · primary_01.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,156 F1 · shares: One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| April 22, 2026 Filed Apr 22, 2026 21:29 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 604 | $95.00 | $57,380.00 |
DisclosureSEC source: 0001040470-26-000148 · primary_01.xml · nonDerivative · entry 2 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 396,375 Read SEC document |
| April 22, 2026 Filed Apr 22, 2026 21:29 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 17,115 | $100.00 | $1,711,500.00 |
DisclosureSEC source: 0001040470-26-000148 · primary_01.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,261 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| April 21, 2026 Filed Apr 21, 2026 22:14 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 8,787 | $96.02 | $843,756.74 |
DisclosureSEC source: 0001040470-26-000136 · primary_01.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,376 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| April 20, 2026 Filed Apr 20, 2026 20:56 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 7,500 | $88.09 | $660,675.00 |
DisclosureSEC source: 0001040470-26-000129 · primary_01.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 396,979 Read SEC document |
| April 17, 2026 Filed Apr 18, 2026 00:33 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 7,500 | $82.00 | $615,000.00 |
DisclosureSEC source: 0001040470-26-000124 · primary_01.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 404,479 Read SEC document |
| April 16, 2026 Filed Apr 16, 2026 23:09 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 15,000 | $80.72 | $1,210,800.00 |
DisclosureSEC source: 0001040470-26-000112 · primary_01.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 411,979 Read SEC document |
| April 09, 2026 Filed Apr 11, 2026 01:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 30,000 | $70.00 | $2,100,000.00 |
DisclosureSEC source: 0001040470-26-000081 · primary_01.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 426,979 Read SEC document |
| February 13, 2026 Filed Feb 13, 2026 21:48 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 13,998 | $30.02 | $420,151.37 |
DisclosureSEC source: 0001040470-26-000054 · primary_01.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 456,979 Read SEC document |
| July 22, 2025 Filed Jul 24, 2025 23:03 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionNon-Qualified Option (right to buy) · Derivative | 18,000 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001593968-25-000880 · primary_01.xml · derivative · entry 4 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,000 shares Expires 2025-08-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 22, 2025 Filed Jul 24, 2025 23:03 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 18,000 | $19.83 | $356,972.40 |
DisclosureSEC source: 0001593968-25-000880 · primary_01.xml · nonDerivative · entry 2 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,163 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| July 22, 2025 Filed Jul 24, 2025 23:03 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 18,000 | $2.40 | $43,200.00 |
DisclosureSEC source: 0001593968-25-000880 · primary_01.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,163 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 21:13 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 10,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-25-000826 · primary_01.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,163 F1 · shares: One-eighth (1/8) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Mr. Rhea Posedel received a required minimum distribution from ESOP plan for CY 2024 of 3,408 shares on 11/04/2024. The closing price was $11.23 per share. Mr. Rhea Posedel received a required minimum distribution from ESOP plan for CY 2025 of 1,409 shares on 4/2/2025. The closing price was $7.84 per share. Mr. Rhea Posedel received 18,115 shares due to the termination of the Company's ESOP plan on 04/25/2025. The closing price was $8.76 per share. Read SEC document |
| February 05, 2025 Filed Feb 6, 2025 02:11 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GiftCommon Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-25-000170 · primary_01.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 470,977 F1 · shares: Represent shares that were gifted to Elizabeth Guilhot, an affiliated person. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| July 11, 2024 Filed Jul 15, 2024 20:48 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 10,589 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-24-000971 · primary_01.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,656 F1 · shares: One-eighth (1/8) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 01:37 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionNon-Qualified Option (right to buy) · Derivative | 18,000 | $0.00 Strike: $3.93 | $0.00 |
DisclosureSEC source: 0001654954-24-001460 · section16.xml · derivative · entry 3 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,000 shares Expires 2024-07-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 01:37 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 18,000 | $3.93 | $70,740.00 |
DisclosureSEC source: 0001654954-24-001460 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,970 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Mr. Rhea Posedel received a required minimum distribution from ESOP plan for CY 2023 of 433 shares on 12/07/2023. The closing price was $24.72 per share. Read SEC document |
| January 31, 2024 Filed Apr 1, 2024 19:02 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-24-000521 · primary_01.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 477,674 F1 · shares: Represents shares that were gifted to Elizabeth Guilhot, an affiliated person. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| November 06, 2023 Filed Nov 15, 2023 01:34 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GiftCommon Stock | 725 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-014380 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 478,674 F1 · shares: Represents shares that were gifted to Elizabeth Guilhot, an affiliated person. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 27, 2023 Filed Oct 28, 2023 01:46 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 5,097 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-013498 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 479,399 F1 · shares: One-eighth (1/8) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| July 18, 2023 Filed Jul 19, 2023 20:04 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 20,000 | $53.00 | $1,060,000.00 |
DisclosureSEC source: 0001654954-23-009404 · section16.xml · nonDerivative · entry 2 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 428,821 F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| July 17, 2023 Filed Jul 19, 2023 20:04 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 80,000 | $51.56 | $4,124,912.00 |
DisclosureSEC source: 0001654954-23-009404 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 448,821 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.87 to $52.39, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| July 11, 2023 Filed Jul 12, 2023 20:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-009084 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 528,821 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| May 17, 2023 Filed May 19, 2023 20:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 18,000 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001654954-23-006938 · section16.xml · derivative · entry 4 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,000 shares Expires 2023-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| May 17, 2023 Filed May 19, 2023 20:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 18,000 | $29.00 | $522,000.00 |
DisclosureSEC source: 0001654954-23-006938 · section16.xml · nonDerivative · entry 2 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,018 Read SEC document |
| May 17, 2023 Filed May 19, 2023 20:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 18,000 | $1.68 | $30,240.00 |
DisclosureSEC source: 0001654954-23-006938 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,018 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 21:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 20,000 | $34.90 | $698,000.00 |
DisclosureSEC source: 0001654954-23-000785 · section16.xml · nonDerivative · entry 2 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 523,821 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2021. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 21:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 20,000 | $32.90 | $658,000.00 |
DisclosureSEC source: 0001654954-23-000785 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 543,821 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2021. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 22:59 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 20,000 | $31.90 | $638,000.00 |
DisclosureSEC source: 0001654954-23-000754 · section16.xml · nonDerivative · entry 2 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 563,821 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2021. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 22:59 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 20,000 | $30.90 | $618,000.00 |
DisclosureSEC source: 0001654954-23-000754 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 583,821 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2021. Read SEC document |
| January 13, 2023 Filed Jan 18, 2023 21:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 19,600 | $29.90 | $586,040.00 |
DisclosureSEC source: 0001654954-23-000553 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 603,821 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2021. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| January 11, 2023 Filed Jan 13, 2023 21:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 400 | $29.95 | $11,980.00 |
DisclosureSEC source: 0001654954-23-000429 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 623,421 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.90 to $29.97, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 23:13 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-013925 · section16.xml · nonDerivative · entry 2 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 623,821 F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 23:13 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 3,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-013925 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 618,821 F1 · shares: One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. Read SEC document |
| April 19, 2022 Filed Apr 20, 2022 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 18,000 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0001654954-22-005202 · section16.xml · derivative · entry 3 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,000 shares Expires 2022-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| April 19, 2022 Filed Apr 20, 2022 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 18,000 | $2.10 | $37,800.00 |
DisclosureSEC source: 0001654954-22-005202 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 615,578 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 21:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 25,000 | $24.91 | $622,750.00 |
DisclosureSEC source: 0001654954-21-011742 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 597,578 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.90 to $25.00, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 26, 2021 Filed Oct 27, 2021 22:15 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-011416 · section16.xml · nonDerivative · entry 2 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 622,578 F2 · shares: The shares were gifted to the Reporting Person's daughter. F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 25, 2021 Filed Oct 27, 2021 22:15 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GiftCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-011416 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 632,578 F1 · shares: The shares were gifted to the Reporting Person's significant other. Read SEC document |
| October 19, 2021 Filed Oct 20, 2021 21:25 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 3,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-011233 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 652,578 F1 · shares: One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 21:07 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 9,400 | $21.05 | $197,903.84 |
DisclosureSEC source: 0001654954-21-011187 · section16.xml · nonDerivative · entry 2 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 649,555 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.1565, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| October 14, 2021 Filed Oct 18, 2021 21:07 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 15,600 | $21.02 | $327,865.20 |
DisclosureSEC source: 0001654954-21-011187 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 658,955 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.15, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| October 11, 2021 Filed Oct 12, 2021 21:02 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 24,000 | $19.93 | $478,320.00 |
DisclosureSEC source: 0001654954-21-011005 · section16.xml · nonDerivative · entry 2 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 674,555 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.90 to $20.10, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| October 08, 2021 Filed Oct 12, 2021 21:02 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 1,000 | $19.90 | $19,900.00 |
DisclosureSEC source: 0001654954-21-011005 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 698,555 Read SEC document |
| October 07, 2021 Filed Oct 9, 2021 00:42 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 20,000 | $15.00 | $300,000.00 |
DisclosureSEC source: 0001654954-21-010948 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 699,555 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 17, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.90 to $15.55, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| September 28, 2021 Filed Sep 30, 2021 20:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 150,000 | $14.08 | $2,112,000.00 |
DisclosureSEC source: 0001654954-21-010599 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 719,555 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 17, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.50 to $14.75, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| August 11, 2021 Filed Aug 12, 2021 20:50 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 22,500 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001654954-21-008856 · section16.xml · derivative · entry 3 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 22,500 shares Expires 2021-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| August 11, 2021 Filed Aug 12, 2021 20:50 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon stock | 22,500 | $2.71 | $60,975.00 |
DisclosureSEC source: 0001654954-21-008856 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 869,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.